Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018

Archive ouverte

Lemaitre, Magali | Fouad, Fayssoil | Carrat, Fabrice | Crepey, Pascal | Gaillat, Jacques | Gavazzi, Gaëtan | Launay, Odile | Mosnier, Anne | Levant, Marie‐cécile | Uhart, Mathieu

Edité par CCSD ; Wiley Open Access -

International audience. BackgroundIn France, each year, influenza viruses are responsible for seasonal epidemics leading to 2–6 million cases. Influenza can cause severe disease that may lead to hospitalization or death. As severe disease may be due to the virus itself or to disease complications, estimating the burden of severe influenza is complex. The present study aimed at estimating the epidemiological and economic burden of severe influenza in France during eight consecutive influenza seasons (2010–2018).MethodsInfluenza-related hospitalization and mortality data and patient characteristics were taken from the French hospital information database, PMSI. An ecological approach using cyclic regression models integrating the incidence of influenza syndrome from the Sentinelles network supplemented the PMSI data analysis in estimating excess hospitalization and mortality (CépiDc—2010–2015) and medical costs.ResultsEach season, the average number of influenza-related hospitalizations was 18,979 (range: 8627–44,024), with an average length of stay of 8 days. The average number of respiratory hospitalizations indirectly related with influenza (i.e., influenza associated) was 31,490 (95% confidence interval [CI]: 24,542–39,012), with an average cost of €141 million (range: 54–217); 70% of these hospitalizations and 77% of their costs concerned individuals ≥65 years of age (65+). More than 90% of excess mortality was in 65+ subjects.ConclusionsThe combination of two complementary approaches allowed estimation of both influenza-related and associated hospitalizations and deaths and their burden in France, showing the substantial impact of complications. The present study highlighted the major public health burden of influenza and its severe complications, especially in 65+ subjects.

Suggestions

Du même auteur

Relative Effectiveness (rVE) of The High-Dose Versus Standard-Dose Influenza Vaccines in the French National health data system (SNDS) for People Aged 65+Living in Community, Obtained Using Two Approaches Based on the Propensity Score

Archive ouverte | Grenier, Benjamin | CCSD

International audience

The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season

Archive ouverte | Bricout, Hélène | CCSD

International audience. Objectives: High-dose quadrivalent influenza vaccine (HD-QIV) was introduced during the 2021/22 influenza season in France for adults aged ≥65 years as an alternative to standard-dose quadriv...

Étude de cohorte rétrospective à l'échelle nationale visant à évaluer l'efficacité vaccinale relative du vaccin grippal haute dose par rapport aux vaccins dose standard chez les adultes de plus de 65 ans vivant en communauté en France au cours de la saison 2022-2023. [P11]

Archive ouverte | Bricout, Hélène | CCSD

International audience. IntroductionDans un essai contrôlé randomisé, le vaccin grippal haute dose (HD) a démontré une efficacité vaccinale relative (eVR) supérieure de 24,2% (9,7;36,5%) par rapport aux vaccins à do...

Chargement des enrichissements...